In clinical practice, the addition of BPC-157 has been associated with improved rather than worsened GI tolerance, consistent with BPC-157's known gastroprotective pharmacology
It is not approved for human or animal use , and may not be used in food, drugs, cosmetics, or diagnostic applications
By potentially lowering inflammation, BPC-157 could support your bodys natural fat-burning processes
Research suggests that Akt-mediated eNOS phosphorylation may increase nitric oxide (NO) bioavailability within vascular tissue microenvironments, potentially supporting vasodilation, microvascular integrity, and organized angiogenic responses in tissues with limited baseline vascular supply such as tendon, ligament, and fibrocartilaginous structures
L., Li, S., Brooks, J
Applications include investigating cancer metastasis prevention, tumor suppression mechanisms, and oncogene regulation strategies